Back to Search
Start Over
TCRvβ8 chimeric antigen receptor natural killer cells exhibit potent preclinical activity against T-cell malignancies.
- Source :
-
Clinical and translational medicine [Clin Transl Med] 2024 Aug; Vol. 14 (8), pp. e70004. - Publication Year :
- 2024
Details
- Language :
- English
- ISSN :
- 2001-1326
- Volume :
- 14
- Issue :
- 8
- Database :
- MEDLINE
- Journal :
- Clinical and translational medicine
- Publication Type :
- Editorial & Opinion
- Accession number :
- 39179525
- Full Text :
- https://doi.org/10.1002/ctm2.70004